Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:06 AM
Ignite Modification Date:
2025-12-25 @ 4:06 AM
NCT ID:
NCT07073820
Eligibility Criteria:
This study is seeking participants who are:
* aged 18 years or older at screening of the previous study and completed the required treatment duration with PF-07868469 and other assessments at the end of that study.
* willing and able to abide with all scheduled visits, treatment plan, laboratory tests, lifestyle considerations, and other study procedures.
* do not have worsening or hospitalization for worsening PAH during the qualifying study.
* not on placement for a surgery to replace any tissue or part of the body (transplant), and planned surgery for PAH.
* do not have an ongoing major health issue in the qualifying study, which in the opinion of the study doctor could make the participant not qualify for this study.
* not suffering from or in the past have suffered from hepato-pulmonary syndrome (liver-related lung problem).
* not currently prescribed or taking medicines called as GLP-1 agonist.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07073820
Study Brief:
Protocol Section:
NCT07073820